Posted inCardiology Diabetes & Endocrinology news
Site-Specific Apo AI Glycation Impairs HDL Function and Promotes Atherosclerosis in Diabetes
This study maps apo AI glycation sites in diabetes, linking them to HDL dysfunction and diabetic atherosclerosis via RAGE-associated signaling, and demonstrates that glycation-resistant apo AI preserves HDL function and lessens atherosclerosis in models.
